Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Achieve Life Sciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +4 vs. Q4 2021
- Shares held
- 1.93M
- +13.5K (+0.7%) vs. Q4 2021
- Total value
- $14.6M
- −$296.0K (−2.0%) vs. Q4 2021
- New holders
- 6
- 7 more added
- Sold out
- 2
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shay Capital LLC | 401,368 | $3.04M | 1.09% | −4,349−1.1% | Reduced |
| Vanguard Group Inc | 342,905 | $2.60M | 0.00% | −2,870−0.8% | Reduced |
| Perkins Capital Management Inc | 174,600 | $1.32M | 1.08% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 125,000 | $946.0K | 0.06% | 00.0% | Unchanged |
| Altium Capital Management LP | 122,000 | $924.0K | 0.32% | 00.0% | Unchanged |
| Clearline Capital LP | 120,094 | $909.0K | 0.12% | −1,918−1.6% | Reduced |
| LPL Financial LLC | 86,550 | $655.0K | 0.00% | +17,600+25.5% | Added |
| Geode Capital Management, LLC | 85,554 | $647.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 80,444 | $609.0K | 0.00% | −19,858−19.8% | Reduced |
| Long Focus Capital Management, LLC | 60,000 | $454.0K | 0.10% | 00.0% | Unchanged |
| DLD Asset Management, LP | 45,528 | $345.0K | 0.02% | +45,528 | New |
| Royal Bank of Canada | 40,400 | $306.0K | 0.00% | −1,000−2.4% | Reduced |
| Franklin Resources Inc | 33,967 | $257.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 25,200 | $191.0K | 0.00% | +1,400+5.9% | Added |
| Oppenheimer & Co Inc | 22,300 | $169.0K | 0.00% | −2,500−10.1% | Reduced |
| State Street Corp | 18,731 | $142.0K | 0.00% | +3,970+26.9% | Added |
| Pura Vida Investments, LLC | 17,325 | $131.0K | 0.02% | +1,000+6.1% | Added |
| Northern Trust Corp | 17,099 | $129.0K | 0.00% | +85+0.5% | Added |
| BlackRock Inc. | 15,207 | $115.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 13,114 | $99.0K | 0.00% | +13,114 | New |
| Two Sigma Advisers, LP | 12,485 | $95.0K | 0.00% | −4,770−27.6% | Reduced |
| Simplex Trading, LLC | 12,486 | $94.0K | 0.00% | +12,145+3,561.6% | Added |
| Paradigm Financial Partners, LLC | 11,750 | $92.0K | 0.02% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 11,001 | $83.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,306 | $79.0K | 0.00% | +10,306 | New |
| Schonfeld Strategic Advisors LLC | 10,200 | $77.0K | 0.00% | +10,200 | New |
| Morgan Stanley | 6,449 | $49.0K | 0.00% | −48,557−88.3% | Reduced |
| Wells Fargo & Company | 5,593 | $42.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,755 | $13.0K | 0.00% | +1,755 | New |
| Advisor Group Holdings, Inc. | 1,643 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,158 | $9.00K | 0.00% | +1,058+1,058.0% | Added |
| Godsey & Gibb Associates | 453 | $3.00K | 0.00% | +453 | New |
| Newbridge Financial Services Group, Inc. | 308 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,207−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −80−100.0% | Sold out |